All Articles

The packaging giant's latest board appointments aren't just a reshuffle; they're a calculated move to embed sustainability and operational might into its core.

Despite better margins, CCSC's net loss ballooned 240%. A deep dive into its costly strategy to pivot towards ESG and a resilient global supply chain.

As Nelnet prepares its Q2 earnings, investors look past the headline numbers to gauge its bold diversification into fiber, banking, and EdTech.

UAE's e& banks $5.95B from its Vodafone sale, refocusing on core assets. But as one giant exits, French telecom tycoon Xavier Niel enters the fray.

A struggling medtech firm and an AI drug developer merge. It's not just a deal; it's a new blueprint for innovation, funded by high-risk capital.

Amidst government announcements, a modest 2% CCB increase offers a lesson in the power of incremental policy and its real-world effect on family finances.

Fintech firm Uplinq's recent workplace award isn't just a trophy. It's a case study in how sustainable growth and employee dedication now define excellence.

As World Cup Final ticket prices soar past $5,400 on average, the beautiful game is becoming an exclusive event. A look at the economic forces pricing fans out.

Community Healthcare Trust's upcoming Q2 earnings are more than just numbers; they're a key indicator of the sector's health amid economic crosswinds.

For decades, a hefty fee was the price of trust in a used car deal. A new startup, Zoooom, is challenging that with AI diagnostics and a disruptive model.

Kibow Biotech's AANP award for its kidney health probiotics isn't just a win for the company; it's a major nod to the growing role of the gut-kidney axis.

Breakwater and Aaru's new platform simulates 40,000 investors to give companies a 'decision advantage', shifting corporate strategy from reactive to predictive.

Recent SEC filings link powerhouse investor Citadel to streaming upstart FreeCast. But as we peel back the layers, a story of high-risk, high-reward emerges.

As LiveWire reports its Q2 results, it faces a paradox: soaring sales and market dominance against crippling losses and fleeing investors. Can it escape its parent's orbit?

A new study reveals the thriving, high-risk market for compounded weight-loss drugs. Even after FDA shortages ended, some clinics use unregulated suppliers.

L7 Informatics hires Ray Veeraraghavan, a former customer and world-record-holding AI architect, to bridge the chasm between AI promise and lab reality.

John and Ann Tickle's record-breaking donation to Ballad Health is more than charity; it's a strategic investment in a region's future and a model for rural wellness.

Toubani Resources’ 19.9% acquisition of Avanti Gold is more than a simple investment. It’s a calculated move that reshapes the African junior gold landscape.

Acrow's win at the NCE Bridges Awards highlights its innovative engineering and collaborative approach, cementing modular construction's role in global infrastructure.

PEO's latest distribution highlights strong performance and a key choice for investors, underscoring its 90-year legacy in a dynamic energy market.